Target Name: OR4D1
NCBI ID: G26689
Review Report on OR4D1 Target / Biomarker Content of Review Report on OR4D1 Target / Biomarker
OR4D1
Other Name(s): Olfactory receptor, family 4, subfamily D, member 4 pseudogene | OR4D1_HUMAN | olfactory receptor, family 4, subfamily D, member 3 | TPCR16 | Olfactory receptor 4D3 | olfactory receptor OR17-23 pseudogene | Olfactory receptor TPCR16 | olfactory receptor, family 4, subfamily D, member 4 pseudogene | OR17-23 | OR4D1 variant 2 | OR4D3 | OR4D4P | Seven transmembrane helix receptor | Olfactory receptor, family 4, subfamily D, member 3 | olfactory receptor TPCR16 | Olfactory receptor OR17-23 pseudogene | olfactory receptor 4D3 | Olfactory receptor family 4 subfamily D member 1, transcript variant 2 | seven transmembrane helix receptor | olfactory receptor family 4 subfamily D member 1 | Olfactory receptor 4D1

OR4D1: A Potential Drug Target for Cancer and Neurodegenerative Diseases

OR4D1 (Olfactory receptor, family 4, subfamily D, member 4 pseudogene) is a gene that encodes a protein known as OR4D1. OR4D1 is a member of the Olfactory receptor family, which is responsible for transmitting sensory information from the nose and mouth to the brain. The OR4D1 gene has been identified as a potential drug target or biomarker due to its involvement in several diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.

The OR4D1 gene is located on chromosome 6p21.2 and has been estimated to contain 1,955 coding exons. OR4D1 is a pseudogene, which means that it is a non-coding gene that has the potential to produce a functional protein. The OR4D1 gene has been shown to encode a protein that is involved in several cellular processes, including cell signaling, neurotransmitter signaling, and immune response.

One of the unique features of OR4D1 is its ability to interact with several different signaling pathways. OR4D1 has been shown to be involved in several signaling pathways, including the TGF-β pathway, the NF-kappa-B pathway, and the PI3K/Akt pathway. These signaling pathways are involved in a wide range of cellular processes, including cell growth, differentiation, migration, and survival.

OR4D1 has also been shown to be involved in the development and progression of several types of cancer, including breast, ovarian, and prostate cancer. In addition, OR4D1 has been linked to the development of neurodegenerative diseases, including Alzheimer's disease and Parkinson's disease.

Due to its involvement in these diseases, OR4D1 has been identified as a potential drug target or biomarker. Researchers are currently working to develop small molecules that can specifically target OR4D1 and inhibit its activity. These small molecules are being tested in a variety of preclinical models, including cell-based assays and animal models of disease.

In addition to its potential as a drug target or biomarker, OR4D1 has also been shown to be involved in several other cellular processes. OR4D1 has been shown to be involved in the regulation of cell adhesion, cell migration, and the production of extracellular matrix (ECM) proteins. OR4D1 has also been shown to play a role in the regulation of neurotransmitter release and synaptic plasticity.

Overall, OR4D1 is a gene that has significant potential as a drug target or biomarker. Its involvement in multiple cellular processes makes it an attractive target for researchers who are looking for new treatments for a wide range of diseases. While further research is needed to fully understand the role of OR4D1 in disease, its potential as a drug target or biomarker is an exciting area of research that is being actively explored.

Protein Name: Olfactory Receptor Family 4 Subfamily D Member 1

Functions: Odorant receptor

The "OR4D1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about OR4D1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

OR4D10 | OR4D11 | OR4D2 | OR4D5 | OR4D6 | OR4D9 | OR4E2 | OR4F13P | OR4F15 | OR4F16 | OR4F17 | OR4F21 | OR4F29 | OR4F3 | OR4F4 | OR4F5 | OR4F6 | OR4G3P | OR4K1 | OR4K13 | OR4K14 | OR4K15 | OR4K17 | OR4K2 | OR4K5 | OR4K6P | OR4K7P | OR4L1 | OR4M1 | OR4M2 | OR4M2-OT1 | OR4N2 | OR4N3P | OR4N4 | OR4N5 | OR4P4 | OR4Q3 | OR4S1 | OR4S2 | OR4T1P | OR4V1P | OR4X1 | OR4X2 | OR51A1P | OR51A2 | OR51A3P | OR51A4 | OR51A6P | OR51A7 | OR51B2 | OR51B4 | OR51B5 | OR51B6 | OR51C1P | OR51D1 | OR51E1 | OR51E2 | OR51F1 | OR51F2 | OR51G1 | OR51G2 | OR51H1 | OR51I1 | OR51I2 | OR51J1 | OR51L1 | OR51M1 | OR51Q1 | OR51S1 | OR51T1 | OR51V1 | OR52A1 | OR52A4P | OR52A5 | OR52B2 | OR52B4 | OR52B6 | OR52D1 | OR52E1 | OR52E2 | OR52E4 | OR52E5 | OR52E6 | OR52E8 | OR52H1 | OR52I1 | OR52I2 | OR52J3 | OR52K1 | OR52K2 | OR52K3P | OR52L1 | OR52M1 | OR52N1 | OR52N4 | OR52N5 | OR52R1 | OR52W1 | OR52Z1P | OR56A1